Persistent short-term memory defects following sleep deprivation in a Drosophila model of Parkinson disease

Sleep

Volumn 32, Issue 8, 2009, Pages 984-992

  Seugnet, Laurent ^a   Galvin, James E ^a   Suzuki, Yasuko ^a   Gottschalk, Laura ^a   Shaw, Paul J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Curcumin; Dopamine; Learning; Parkinson's Disease; Short term memory

Indexed keywords

ALPHA SYNUCLEIN; CURCUMIN; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR; MELATONIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DROSOPHILA; DRUG MECHANISM; EXPERIMENTAL MODEL; GENE EXPRESSION; LEARNING DISORDER; MEMORY DISORDER; NERVE CELL NECROSIS; NONHUMAN; PARKINSON DISEASE; PHOTOTAXIS; PRIORITY JOURNAL; SHORT TERM MEMORY; SLEEP DEPRIVATION; TRANSGENIC ANIMAL;

EID: 70349143217     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.1093/sleep/32.8.984     Document Type: Article

References (71)

1. Bosboom JL, Stoffers D, Wolters E. Cognitive dysfunction and dementia in Parkinson's disease. J Neural Transm 2004;111:1303-1315 (Pubitemid 39468392)
2. Owen AM, James M, Leigh PN, et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992;115:1727-1751 (Pubitemid 23054862)
3. Foltynie T, Goldberg TE, Lewis SG, et al. Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism. Mov Disord 2004;19:885-891 (Pubitemid 39199254)
4. Galvin JE. Cognitive change in Parkinson disease. Alzheimer Dis Assoc Disord 2006;20:302-310
5. Green J, McDonald WM, Vitek JL, et al. Cognitive impairments in advanced PD without dementia. Neurology 2002;59:1320-1324 (Pubitemid 35285980)
6. Schapira AH. Excessive daytime sleepiness in Parkinson's disease. Neurology 2004;63(8 Suppl 3):S24-7.
7. Pal PK, Thennarasu K, Fleming J, Schulzer M, Brown T, Calne SM. Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson's disease and in their caregivers. Parkinsonism Relat Disord 2004;10:157-168 (Pubitemid 38251660)
8. Bliwise DL, Watts RL, Watts N, Rye DB, Irbe D, Hughes M. Disruptive nocturnal behavior in Parkinson's disease and Alzheimer's disease. J Geriatr Psychiatry Neurol 1995;8:107-110
9. Rye DB. Excessive daytime sleepiness and unintended sleep in Parkinson's disease. Curr Neurol Neurosci Rep 2006;6:169-176
10. Boeve BF, Silber MH, Ferman TJ, et al. REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease. Neurology 1998;51:363-370
11. Vendette M, Gagnon JF, Decary A, et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology 2007;69:1843-1849 (Pubitemid 350071145)
12. Marion MH, Qurashi M, Marshall G, Foster O. Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease? J Neurol 2008;255:192-196
13. Thannickal TC, Lai YY, Siegel JM. Hypocretin (orexin) cell loss in Parkinson's disease. Brain 2007;130:1586-1595 (Pubitemid 47355933)
14. Friedman JH, Chou KL. Sleep and fatigue in Parkinson's disease. Parkinsonism Relat Disord 2004;10 Suppl 1:S27-35.
15. Dzirasa K, Ribeiro S, Costa R, et al. Dopaminergic control of sleep-wake states. J Neurosci 2006;26(41):10577-10589
16. Kume K, Kume S, Park SK, Hirsh J, Jackson FR. Dopamine is a regulator of arousal in the fruit fly. J Neurosci 2005;25:7377-7384 (Pubitemid 41129810)
17. Andretic R, van Swinderen B, Greenspan RJ. Dopaminergic modulation of arousal in Drosophila. Curr Biol 2005;15:1165-1175
18. Shaw PJ, Cirelli C, Greenspan RJ, Tononi G. Correlates of sleep and waking in Drosophila melanogaster. Science 2000;287:1834-1837 (Pubitemid 30143970)
19. Cirelli C, Gutierrez CM, Tononi G. Extensive and divergent effects of sleep and wakefulness on brain gene expression. Neuron 2004;41:35-43. (Pubitemid 38068433)
20. Greenspan RJ, Tononi G, Cirelli C, Shaw PJ. Sleep and the fruit fly. Trends Neurosci 2001;24:142-145
21. Seugnet L, Suzuki Y, Vine L, Gottschalk L, Shaw PJ. D1 Receptor Activation in the Mushroom Bodies Rescues Sleep-Loss-Induced Learning Impairments in Drosophila. Curr Biol 2008;18:1110-1117
22. Volkow ND, Wang GJ, Telang F, et al. Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain. J Neurosci 2008;28:8454-8461
23. Ganguly-Fitzgerald I, Donlea J, Shaw PJ. Waking experience affects sleep need in Drosophila. Science 2006;313:1775-1781 (Pubitemid 44454152)
24. Friedman E, Wang HY. Prenatal cocaine exposure alters signal transduction in the brain D1 dopamine receptor system. Ann N Y Acad Sci 1998;846:238-247 (Pubitemid 28365397)
25. Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 1993;118(2):401-415 (Pubitemid 23214028)
26. Pendleton RG, Parvez F, Sayed M, Hillman R. Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. J Pharmacol Exp Ther 2002;300:91-96 (Pubitemid 34028513)
27. Feany MB, Bender WW. A Drosophila model of Parkinson's disease. Nature 2000;404:394-398
28. Le Bourg E, Buecher C. Learned suppression of photopositive tendencies in Drosophila melanogaster. Anim Learn Behav 2002;30:330-341 (Pubitemid 36056759)
29. Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 2005;39:1119-1125 (Pubitemid 41358566)
30. Pandey N, Strider J, Nolan WC, Yan SX, Galvin JE. Curcumin inhibits aggregation of alpha-synuclein. Acta Neuropathol 2008;115:479-489
31. Shaw PJ, Tononi G, Greenspan RJ, Robinson DF. Stress response genes protect against lethal effects of sleep deprivation in Drosophila. Nature 2002;417:287-291
32. Feng G, Hannan F, Reale V, et al. Cloning and functional characterization of a novel dopamine receptor from Drosophila melanogaster. J Neurosci 1996;16:3925-3933 (Pubitemid 26176056)
33. Miller RM, Federoff HJ. Microarrays in Parkinson's disease: a systematic approach. NeuroRx 2006;3:319-326 (Pubitemid 43946714)
34. Seugnet L, Suzuki Y, Stidd R, Shaw PJ. Aversive Phototaxic Suppression: evaluation of a short-term memory assay in Drosophila melanogaster. Genes Brain Behav 2009 Feb 11 [Epub ahead of print]
35. Auluck PK, Bonini NM. Pharmacological prevention of Parkinson disease in Drosophila. Nat Med 2002;8:1185-1186
36. Dabbeni-Sala F, Di Santo S, Franceschini D, Skaper SD, Giusti P. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J 2001;15:164-170 (Pubitemid 32061667)
37. Coulom H, Birman S. Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster. J Neurosci 2004;24:10993-10998 (Pubitemid 39602410)
38. Ma J, Shaw VE, Mitrofanis J. Does melatonin help save dopaminergic cells in MPTP-treated mice? Parkinsonism Relat Disord 2008 Sept 13 [Epub ahead of print].
39. Benmoyal-Segal L, Soreq H. Gene-environment interactions in sporadic Parkinson's disease. J Neurochem 2006;97:1740-1755 (Pubitemid 43873664)
40. Pfeiffer RF. Non-motor parkinsonism. Parkinsonism Relat Disord 2007;13 Suppl 3:S211-20.
41. Bonini NM, Fortini ME. Human neurodegenerative disease modeling using Drosophila. Annu Rev Neurosci 2003;26:627-656 (Pubitemid 37064946)
42. Lang AE, Lozano AM. Parkinson's disease. First of two parts. N Engl J Med 1998;339:1044-1053
43. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211. (Pubitemid 36007810)
44. Lemon N, Manahan-Vaughan D. Dopamine D1/D5 receptors gate the acquisition of novel information through hippocampal long-term potentiation and long-term depression. J Neurosci 2006;26:7723-7729 (Pubitemid 44315192)
45. Battaglia F, Ghilardi MF, Quartarone A, Bagnato S, Girlanda P, Hallett M. Impaired long-term potentiation-like plasticity of the trigeminal blink reflex circuit in Parkinson's disease. Mov Disord 2006;21:2230-2233 (Pubitemid 46140446)
46. Imai Y, Gehrke S, Wang HQ, et al. Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J 2008;27:2432-2443
47. Neckameyer WS, Woodrome S, Holt B, Mayer A. Dopamine and senescence in Drosophila melanogaster. Neurobiol Aging 2000;21:145-152
48. Le Bourg E. Effects of aging on learned suppression of photo-positive tendencies in Drosophila melanogaster. Neurobiol Aging 2004;25:1241-1252 (Pubitemid 39094027)
49. Helmich RC, de Lange FP, Bloem BR, Toni I. Cerebral compensation during motor imagery in Parkinson's disease. Neuropsychologia 2007;45:2201-2215 (Pubitemid 46678107)
50. Bezard E, Gross CE, Brotchie JM. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated. Trends Neurosci 2003;26:215-221 (Pubitemid 36412004)
51. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 1990;13:290-296
52. Martin-Pena A, Acebes A, Rodriguez JR, et al. Age-independent synaptogenesis by phosphoinositide 3 kinase. J Neurosci 2006;26:10199-10208
53. Heisenberg M, Heusipp M, Wanke C. Structural plasticity in the Drosophila brain. J Neurosci 1995;15(3 Pt 1):1951-1960
54. Kramer ML, Schulz-Schaeffer WJ. Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci 2007;27:1405-1410
55. Miller JC, Friedhoff AJ. Prenatal neurotransmitter programming of postnatal receptor function. Prog Brain Res 1988;73:509-522
56. Park SS, Schulz EM, Lee D. Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein. Eur J Neurosci 2007;26:3104-3112 (Pubitemid 350135175)
57. Bertolucci PH, Andrade LA, Lima JG, Carlini EA. Total sleep deprivation and Parkinson disease. Arq Neuropsiquiatr 1987;45:224-230
58. Reist C, Sokolski KN, Chen CC, Coskinas E, Demet EM. The effect of sleep deprivation on motor impairment and retinal adaptation in Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:445-454
59. Hogl B, Peralta C, Wetter TC, Gershanik O, Trenkwalder C. Effect of sleep deprivation on motor performance in patients with Parkinson's disease. Mov Disord 2001;16:616-621 (Pubitemid 36040840)
60. Hogl BE, Gomez-Arevalo G, Garcia S, et al. A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson's disease. Neurology 1998;50:1332-1339 (Pubitemid 28240348)
61. Merello M, Hughes A, Colosimo C, Hoffman M, Starkstein S, Leiguarda R. Sleep benefit in Parkinson's disease. Mov Disord 1997;12:506-508
62. Bateman DE, Levett K, Marsden CD. Sleep benefit in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;67:384-385
63. Marinelli L, Crupi D, Di Rocco A, et al. Learning and consolidation of visuo-motor adaptation in Parkinson's disease. Parkinsonism Relat Disord 2009;15:6-11.
64. Morgan WW, Nelson JF. Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway. Brain Res 2001;921:115-121
65. Zisapel N. Melatonin-dopamine interactions: from basic neurochemistry to a clinical setting. Cell Mol Neurobiol 2001;21:605-616 (Pubitemid 34538858)
66. Marsh JL, Thompson LM. Drosophila in the study of neurodegenerative disease. Neuron 2006;52:169-178
67. Muqit MM, Feany MB. Modelling neurodegenerative diseases in Drosophila: a fruitful approach? Nat Rev Neurosci 2002;3:237-243
68. McBride SM, Choi CH, Wang Y, et al. Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 2005;45:753-764 (Pubitemid 40320709)
69. Garcia-Garcia F, Ponce S, Brown R, Cussen V, Krueger JM. Sleep disturbances in the rotenone animal model of Parkinson disease. Brain Res 2005;1042:160-168 (Pubitemid 40591725)
70. Monaca C, Laloux C, Jacquesson JM, et al. Vigilance states in a parkinsonian model, the MPTP mouse. Eur J Neurosci 2004;20:2474-2478 (Pubitemid 39472409)
71. Almirall H, Pigarev I, de la Calzada MD, Pigareva M, Herrero MT, Sagales T. Nocturnal sleep structure and temperature slope in MPTP treated monkeys. J Neural Transm 1999;106:1125-1134 (Pubitemid 30009210)